cataracts

From Aaushi
Jump to navigation Jump to search

Introduction

An opacity of the crystalline lens of the eye; a loss of transparency of the lens of the eye or of its capsule.

Etiology

(risk factors)

Epidemiology

Pathology

Genetics

Clinical manifestations

Laboratory

Complications

Management

Comparative biology

More general terms

More specific terms

Additional terms

References

  1. Harrison's Principles of Internal Medicine, 13th ed. Companion Handbook, Isselbacher et al (eds), McGraw-Hill Inc. NY, 1995, pg 829-39.
  2. DeGowin & DeGowin's Diagnostic Examination, 6th edition, RL DeGowin (ed), McGraw Hill, NY 1994, pg 872
  3. 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 11, 15, American College of Physicians, Philadelphia 1998, 2009
  4. 4.0 4.1 Journal Watch 21(1):3, 2001 Mares-Perlman et al Arch Ophthalmol 118:1556, 2000
  5. 5.0 5.1 Mangione C. In: Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 12-15, 2001
  6. 6.0 6.1 Jacques PF, Taylor A, Moeller S Long-term nutrient intake and 5-year change in nuclear lens opacification, Archives of Ophthalmology 123:517, 2005
  7. 7.0 7.1 Klein BEK et al, Statin use and incident nuclear cataract. JAMA 2006; 295:2752 PMID: https://www.ncbi.nlm.nih.gov/pubmed/16788130
  8. 8.0 8.1 8.2 Geriatric Review Syllabus, 7th edition Parada JT et al (eds) American Geriatrics Society, 2010
  9. Asbell PA, Dualan I, Mindel J, Brocks D, Ahmad M, Epstein S. Age-related cataract. Lancet. 2005 Feb 12-18;365(9459):599-609. PMID: https://www.ncbi.nlm.nih.gov/pubmed/15708105
  10. Bienfang DC, Kelly LD, Nicholson DH, Nussenblatt RB Ophthalmology. N Engl J Med. 1990 Oct 4;323(14):956-67. PMID: https://www.ncbi.nlm.nih.gov/pubmed/2205800
  11. 11.0 11.1 Delcourt C et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA study. Am J Epidemiol 2000 Mar 9; 151:497-504 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11004323
  12. 12.0 12.1 12.2 12.3 12.4 Zhao L et al. Lanosterol reverses protein aggregation in cataracts. Nature 2015 Jul 30; 523:607. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26200341
    Makley LN et al. Pharmacological chaperone for alpha-crystallin partially restores transparency in cataract models. Science 2015 Nov 6; 350:674. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26542570
    Quinlan RA. A new dawn for cataracts: Sterols reverse protein aggregation in an eye lens paradigm. Science 2015 Nov 6; 350:636. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26542559
  13. Lamoureux EL, Fenwick E, Pesudovs K, Tan D. The impact of cataract surgery on quality of life. Curr Opin Ophthalmol. 2011 Jan;22(1):19-27. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/21088580
  14. 14.0 14.1 Hobbs BN Seeing Red: Five Eye Diagnoses Not to Miss Medscape - Apr 23, 2018. https://www.medscape.com/viewarticle/895295
  15. Iroku-Malize T, Kirsch S. Eye Conditions in Older Adults: Cataracts. FP Essent. 2016 Jun;445:17-23. PMID: https://www.ncbi.nlm.nih.gov/pubmed/ 27348528 Review.
  16. Pelletier AL, Rojas-Roldan L, Coffin J. Vision Loss in Older Adults. Am Fam Physician. 2016 Aug 1;94(3):219-26. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27479624 Free article. Review.
  17. 17.0 17.1 Tsang JY et al. Risk of falls and fractures in individuals with cataract, age-related macular degeneration, or glaucoma. JAMA Ophthalmol 2023 Dec 28; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38153708 https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2813168

Patient information

cataracts patient information